Healthcare provider profile · identity verified

William R Turner, MD

Family Practice · DYERSBURG, TN · NPI 1144215187

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Meloxicam	Meloxicam	328	98
Amlodipine Besylate	Amlodipine Besylate	320	85
Atorvastatin Calcium	Atorvastatin Calcium	288	92
Metformin Hcl	Metformin Hcl	278	66
Hydrochlorothiazide	Hydrochlorothiazide	247	72
Lisinopril	Lisinopril	237	65
Pantoprazole Sodium	Pantoprazole Sodium	210	58
Simvastatin	Simvastatin	205	51
Levothyroxine Sodium	Levothyroxine Sodium	196	52
Potassium Chloride	Potassium Chloride	196	52
Fenofibrate	Fenofibrate	186	58
Losartan Potassium	Losartan Potassium	178	50
Omeprazole	Omeprazole	174	52
Azithromycin	Azithromycin	165	113
Clopidogrel	Clopidogrel Bisulfate	152	43
Gabapentin	Gabapentin	136	20
Furosemide	Furosemide	135	39
Eliquis	Apixaban	120	15
Amoxicillin	Amoxicillin	111	84
Rosuvastatin Calcium	Rosuvastatin Calcium	108	29
Albuterol Sulfate Hfa	Albuterol Sulfate	106	32
Famotidine	Famotidine	94	24
Metoprolol Tartrate	Metoprolol Tartrate	94	33
Metoprolol Succinate	Metoprolol Succinate	87	26
Carvedilol	Carvedilol	75	21
Citalopram Hbr	Citalopram Hydrobromide	74	23
Lovastatin	Lovastatin	74	21
Fluticasone Propionate	Fluticasone Propionate	73	21
Glimepiride	Glimepiride	73	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	20
Pravastatin Sodium	Pravastatin Sodium	68	19
Sertraline Hcl	Sertraline Hcl	66	16
Alprazolam	Alprazolam	63	suppressed
Allopurinol	Allopurinol	56	16
Escitalopram Oxalate	Escitalopram Oxalate	55	20
Atenolol	Atenolol	54	16
Gemfibrozil	Gemfibrozil	54	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	51	38
Fenofibrate	Fenofibrate Nanocrystallized	49	17
Spironolactone	Spironolactone	49	12
Montelukast Sodium	Montelukast Sodium	48	12
Ezetimibe	Ezetimibe	47	16
Pioglitazone Hcl	Pioglitazone Hcl	45	14
Doxycycline Hyclate	Doxycycline Hyclate	44	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	12
Prednisone	Prednisone	43	32
Clonidine Hcl	Clonidine Hcl	42	12
Diclofenac Sodium	Diclofenac Sodium	41	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	33
Hydralazine Hcl	Hydralazine Hcl	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	suppressed
Donepezil Hcl	Donepezil Hcl	38	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	38	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	29
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Metformin Hcl Er	Metformin Hcl	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Temazepam	Temazepam	33	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Alendronate Sodium	Alendronate Sodium	31	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Fluconazole	Fluconazole	30	18
Trazodone Hcl	Trazodone Hcl	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	15
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	18
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	15
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	21	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Naproxen	Naproxen	19	suppressed
Primidone	Primidone	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Cephalexin	Cephalexin	18	17
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Methylprednisolone	Methylprednisolone	17	15
Tramadol Hcl	Tramadol Hcl	17	suppressed
Baclofen	Baclofen	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Digoxin	Digoxin	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	14	14
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Glipizide	Glipizide	13	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error